Deciphera Pharmaceuticals stock has broken below its 200 day moving average line firing a MAJOR bear signal.
The PPI coming in hotter than expected tanked a lot of biotech stocks that are not profitable and that are raising money through dilution. Dilution not so easy to convert into money in a reducing liquidity macroenvironment.

On January 24, 2023, a cluster of J.P. Morgan, Jefferies, Cowen, and Guggenheim Securities ran around pitching $DCPH stock to clients to raise $143 million.